Fremer, Carolin http://orcid.org/0000-0002-9585-7415
Szejko, Natalia http://orcid.org/0000-0001-6160-9221
Pisarenko, Anna
Haas, Martina
Laudenbach, Luise
Wegener, Claudia
Müller-Vahl, Kirsten R. http://orcid.org/0000-0002-7181-7419
Funding for this research was provided by:
Medizinische Hochschule Hannover (MHH)
Article History
Received: 13 October 2022
Accepted: 29 March 2023
First Online: 20 May 2023
Declarations
:
: Carolin Fremer, Natalia Szejko, Anna Pisarenko, Martina Haas, Luise Laudenbach and Claudia Wegener declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.Kirsten Müller-Vahl has received financial or material research support from EU (FP7-HEALTH-2011 No. 278367, FP7-PEOPLE-2012-ITN No. 316978) DFG: GZ MU 1527/3–1 and GZ MU 1527/3–2, BMBF: 01KG1421, National Institute of Mental Health (NIMH), Tourette Gesellschaft Deutschland e.V. Else-Kröner-Fresenius-Stiftung, GW pharmaceuticals, Almirall Hermal GmbH, Abide Therapeutics, and Therapix Biosiences. She has received consultant's honoraria from Abide Therapeutics, Boehringer Ingelheim International GmbH, Bionorica Ethics GmbH, CannaMedical Pharma GmbH, Canopy Grouth, Columbia Care, CTC Communications Corp., Demecan, Eurox Deutschland GmbH, Global Praxis Group Limited, IMC Germany, Lundbeck, Sanity Group, Stadapharm GmbH, Synendos Therapeutics AG, and Tilray. She is an advisory/scientific board member for CannaMedical Pharma GmbH, Bionorica Ethics GmbH, CannaXan GmbH, Canopy Growth, Columbia Care, IMC Germany, Leafly Deutschland GmbH, Sanity Group, Syqe Medical Ltd., Therapix Biosciences Ltd., and Wayland Group. She has received speaker’s fees from Aphria Deutschland GmbH, Almirall, Cogitando GmbH, Emalex, Eurox Deutschland GmbH, Ever pharma GmbH, Meinhardt Congress GmbH, PR Berater, Spectrum Therapeutics GmbH, Takeda GmbH, Tilray, Wayland Group. She has received royalties from Deutsches Ärzteblatt, Der Neurologe und Psychiater, Elsevier, Medizinisch Wissenschaftliche Verlagsgesellschaft Berlin, and Kohlhammer. She served as a guest editor for Frontiers in Neurology on the research topic “The neurobiology and genetics of Gilles de la Tourette syndrome: new avenues through large-scale collaborative projects”, is an associate editor for “Cannabis and Cannabinoid Research” and an Editorial Board Member of “Medical Cannabis and Cannabinoids” und “MDPI-Reports” and a Scientific board member for “Zeitschrift für Allgemeinmedizin”.
: The study was reviewed and approved by Local Ethics Committee at Hannover Medical School (No. 8995_BO_S_2020).
: Written informed consent to participate in this study was provided by the participants and their legal guardian.